reports
- Dave Nicoski
- Ross LaDuke
Vermilion Int'l Compass: Global Equity Strategy
Japan and Europe Holding Below Resistance Our outlook remains neutral on global equities (MSCI ACWI) as of our August 8, 2024 Int'l Compass, after being bullish since early-November 2023. In late-July (7/25/24 Int'l Compass) we discussed expectations for a 1- to 4-month pullback/consolidation period on MSCI ACWI (ACWI-US), and we believe it seems likely to last closer to four months, and potentially 4- to 6-months from our selected 7/17/24 starting point, until the market decides which way this...
Investor Alert (NYSE: AGL): Kessler Topaz Meltzer & Check, LLP Files a...
RADNOR, Pa.--(BUSINESS WIRE)-- The law firm of informs investors that today the firm has filed a against agilon health, inc. () (“agilon” or the “Company”) on behalf of investors who purchased or acquired agilon common stock between November 4, 2022, and January 4, 2024, inclusive (the “Class Period”). This action, captioned Hope v. agilon health, inc., et al., Case No. 1:24-cv-00305, is filed in the United States District Court for the Western District Texas. Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
VCYT VERACYTE INC
RDUS RADIUS HEALTH INC.
FOLD AMICUS THERAPEUTICS INC.
CYTK CYTOKINETICS INCORPORATED
AVXL ANAVEX LIFE SCIENCES
AGIO AGIOS PHARMACEUTICALS INC.
NTLA INTELLIA THERAPEUTICS INC.
CYRX CRYOPORT INC.
DH DELICE HOLDING
FNKO FUNKO CLASS A
RCKT ROCKET PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
ALEC ALECTOR
RAD RITE AID CORPORATION
TMDX TRANSMEDICS GROUP
CHWY CHEWY INC. CLASS A
HCAT HEALTH CATALYST
RAPT RAPT THERAPEUTICS
ALT ALTIMMUNE INC
AVEO AVEO PHARMACEUTICALS INC.
SPT SPROUT SOCIAL
FSTX F-STAR THERAPEUTICS INC
MASS 908 DEVICES
DAWN DAY ONE BIOPHARMACEUTICALS INC
GTLB GITLAB INC
AGL AGILON HEALTH INC
VERV VERVE THERAPEUTICS INC
GLUE MONTE ROSA THERAPEUTICS INC
BRZE BRAZE INC
RXRX RECURSION PHARMACEUTICALS INC
JANX JANUX THERAPEUTICS INC
WEBR WEBER INC
AGILON HEALTH sees an upgrade to Slightly Positive due to a better fun...
The general evaluation of AGILON HEALTH (US), a company active in the Health Care Providers industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date February 15, 2022, the closing pri...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.